{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Saroglitazar+Magnesium+4+mg", "query": { "intervention": "Saroglitazar Magnesium 4 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 12, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Saroglitazar+Magnesium+4+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-01T22:38:18.266Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04469920", "title": "Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatic Impairment" ], "interventions": [ { "name": "Saroglitazar Magnesium 2 mg", "type": "DRUG" }, { "name": "Saroglitazar Magnesium 4 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 98, "start_date": "2020-07-16", "completion_date": "2022-03-21", "has_results": false, "last_update_posted_date": "2024-09-20", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 2, "location_summary": "Indianapolis, Indiana • San Antonio, Texas", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04469920" }, { "nct_id": "NCT05011305", "title": "Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nonalcoholic Steatohepatitis", "Fibrosis" ], "interventions": [ { "name": "Saroglitazar Magnesium 2 mg", "type": "DRUG" }, { "name": "Saroglitazar Magnesium 4 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 189, "start_date": "2021-08-18", "completion_date": "2025-09-12", "has_results": false, "last_update_posted_date": "2025-10-24", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Phoenix, Arizona + 75 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05011305" }, { "nct_id": "NCT03112681", "title": "Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Biliary Cirrhosis" ], "interventions": [ { "name": "Saroglitazar magnesium 2 mg", "type": "DRUG" }, { "name": "Saroglitazar magnesium 4 mg", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 37, "start_date": "2017-08-18", "completion_date": "2020-08-07", "has_results": true, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 9, "location_summary": "Pasadena, California • Miami, Florida • Marietta, Georgia + 5 more", "locations": [ { "city": "Pasadena", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03112681" }, { "nct_id": "NCT03863574", "title": "Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non Alcoholic Steatohepatitis" ], "interventions": [ { "name": "Saroglitazar Magnesium 2mg", "type": "DRUG" }, { "name": "Saroglitazar Magnesium 4mg", "type": "DRUG" }, { "name": "Placebos", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 16, "start_date": "2019-06-12", "completion_date": "2020-03-20", "has_results": true, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 6, "location_summary": "Jackson, Mississippi • Germantown, Tennessee • Hermitage, Tennessee + 2 more", "locations": [ { "city": "Jackson", "state": "Mississippi" }, { "city": "Germantown", "state": "Tennessee" }, { "city": "Hermitage", "state": "Tennessee" }, { "city": "San Antonio", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03863574" }, { "nct_id": "NCT03097107", "title": "Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidemias" ], "interventions": [ { "name": "Saroglitazar Magnesium 1 mg", "type": "DRUG" }, { "name": "Saroglitazar Magnesium 2 mg", "type": "DRUG" }, { "name": "Saroglitazar Magnesium 4 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 124, "start_date": "2017-04-06", "completion_date": "2024-01", "has_results": false, "last_update_posted_date": "2023-02-08", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 33, "location_summary": "Huntsville, Alabama • Encinitas, California • San Diego, California + 29 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Encinitas", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03097107" }, { "nct_id": "NCT03617263", "title": "Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-alcoholic Fatty Liver Disease in Women With PCOS" ], "interventions": [ { "name": "Saroglitazar Magnesium 4 mg Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 60, "start_date": "2019-02-12", "completion_date": "2024-10-28", "has_results": true, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 13, "location_summary": "Chandler, Arizona • Panorama City, California • San Francisco, California + 9 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Panorama City", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03617263" }, { "nct_id": "NCT04446507", "title": "A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects with Severe Renal Impairment and Normal Renal Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Renal Impairment" ], "interventions": [ { "name": "Saroglitazar magnesium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 32, "start_date": "2020-07-27", "completion_date": "2024-05-28", "has_results": false, "last_update_posted_date": "2024-09-20", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 2, "location_summary": "DeLand, Florida • San Antonio, Texas", "locations": [ { "city": "DeLand", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04446507" }, { "nct_id": "NCT05211284", "title": "Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nonalcoholic Fatty Liver Disease" ], "interventions": [ { "name": "Saroglitazar Magnesium 4 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2022-12-08", "completion_date": "2023-10-02", "has_results": true, "last_update_posted_date": "2025-09-02", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 8, "location_summary": "Birmingham, Alabama • La Jolla, California • San Francisco, California + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05211284" }, { "nct_id": "NCT03639623", "title": "Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Liver Transplant; Complications", "NAFLD" ], "interventions": [ { "name": "Saroglitazar", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 20, "start_date": "2019-02-25", "completion_date": "2021-12-13", "has_results": true, "last_update_posted_date": "2024-10-24", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03639623" }, { "nct_id": "NCT04112446", "title": "Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Saroglitazar magnesium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zydus Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 8, "start_date": "2019-09-20", "completion_date": "2019-10-29", "has_results": false, "last_update_posted_date": "2019-11-13", "last_synced_at": "2026-09-01T22:38:18.266Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04112446" } ] }